Cancer Predisposition Genes in Cancer-Free Families.

high-risk genes polygenic risk predisposing genes random environment

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Sep 2020
Historique:
received: 10 08 2020
revised: 21 09 2020
accepted: 24 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

Familial clustering, twin concordance, and identification of high- and low-penetrance cancer predisposition variants support the idea that there are families that are at a high to moderate excess risk of cancer. To what extent there may be families that are protected from cancer is unknown. We wanted to test genetically whether cancer-free families share fewer breast, colorectal, and prostate cancer risk alleles than the population at large. We addressed this question by whole-genome sequencing (WGS) of 51 elderly cancer-free individuals whose numerous (ca. 1000) family members were found to be cancer-free ('cancer-free families', CFFs) based on face-to-face interviews. The average coverage of the 51 samples in the WGS was 42x. We compared cancer risk allele frequencies in cancer-free individuals with those in the general population available in public databases. The CFF members had fewer loss-of-function variants in suggested cancer predisposition genes compared to the ExAC data, and for high-risk cancer predisposition genes, no pathogenic variants were found in CFFs. For common low-penetrance breast, colorectal, and prostate cancer risk alleles, the results were not conclusive. The results suggest that, in line with twin and family studies, random environmental causes are so dominant that a clear demarcation of cancer-free populations using genetic data may not be feasible.

Identifiants

pubmed: 32992489
pii: cancers12102770
doi: 10.3390/cancers12102770
pmc: PMC7600438
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
Nat Genet. 2018 Sep;50(9):1212-1218
pubmed: 30158684
Hum Mutat. 2013 Jan;34(1):57-65
pubmed: 23033316
Genome Res. 2005 Aug;15(8):1034-50
pubmed: 16024819
Int J Cancer. 2017 Apr 1;140(7):1510-1516
pubmed: 28006863
Nat Methods. 2010 Aug;7(8):575-6
pubmed: 20676075
J Invest Dermatol. 2018 Dec;138(12):2617-2624
pubmed: 29890168
PLoS One. 2009;4(5):e5472
pubmed: 19424496
Gastroenterology. 2020 Apr;158(5):1274-1286.e12
pubmed: 31866242
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Eur J Hum Genet. 2008 Dec;16(12):1413-29
pubmed: 19020537
Genome Res. 2009 Sep;19(9):1553-61
pubmed: 19602639
PLoS Genet. 2013;9(8):e1003709
pubmed: 23990802
Forensic Sci Int Genet. 2014 Jul;11:182-94
pubmed: 24793845
Int J Cancer. 2002 May 10;99(2):260-6
pubmed: 11979442
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):380-394
pubmed: 29382703
Prostate. 2015 Apr 1;75(5):474-83
pubmed: 25560306
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Acad Emerg Med. 2005 Apr;12(4):360-5
pubmed: 15805329
Nucleic Acids Res. 2000 Jan 1;28(1):352-5
pubmed: 10592272
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Nat Commun. 2020 Jan 23;11(1):435
pubmed: 31974348
Nature. 2014 Jan 16;505(7483):302-8
pubmed: 24429628
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Nat Genet. 2019 Jan;51(1):76-87
pubmed: 30510241
Cell. 2018 Apr 5;173(2):355-370.e14
pubmed: 29625052
Int J Cancer. 2012 Nov 1;131(9):2085-93
pubmed: 22307919
Genome Res. 2005 Jul;15(7):901-13
pubmed: 15965027
Genet Med. 2018 Dec;20(12):1677-1686
pubmed: 29988077
Oncotarget. 2016 Jun 21;7(25):37803-37811
pubmed: 27192119
PLoS One. 2013;8(1):e54360
pubmed: 23342138
J Med Genet. 2017 Apr;54(4):248-253
pubmed: 27651446
Nucleic Acids Res. 2011 Sep 1;39(17):e118
pubmed: 21727090
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Hum Mutat. 2016 Mar;37(3):235-41
pubmed: 26555599
Sci Rep. 2018 Aug 2;8(1):11635
pubmed: 30072699
Gastroenterology. 2018 Jul;155(1):88-98.e10
pubmed: 29574091
Am J Hum Genet. 2018 Oct 4;103(4):522-534
pubmed: 30269813
Nat Commun. 2016 Jul 01;7:12050
pubmed: 27363682
Nat Genet. 2018 Jul;50(7):928-936
pubmed: 29892016
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
J Natl Cancer Inst. 2015 Oct 12;107(12):djv279
pubmed: 26464424
J Natl Cancer Inst. 2019 Feb 1;111(2):146-157
pubmed: 29917119
Nat Rev Cancer. 2017 Nov;17(11):692-704
pubmed: 29026206
J Clin Oncol. 2015 Feb 10;33(5):426-32
pubmed: 25559809
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
Genet Med. 2015 Jan;17(1):24-6
pubmed: 25375653
Genome Res. 2010 Jan;20(1):110-21
pubmed: 19858363
Eur J Hum Genet. 2019 May;27(5):824-828
pubmed: 30718883

Auteurs

Guoqiao Zheng (G)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.

Calogerina Catalano (C)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.

Obul Reddy Bandapalli (OR)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
Medical Faculty, University of Heidelberg, 69120 Heidelberg, Germany.

Nagarajan Paramasivam (N)

Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.

Subhayan Chattopadhyay (S)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.

Matthias Schlesner (M)

Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Rolf Sijmons (R)

Department of Genetics, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.

Akseli Hemminki (A)

Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.
Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland.

Dagmara Dymerska (D)

Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.

Jan Lubinski (J)

Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.

Kari Hemminki (K)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic.
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Asta Försti (A)

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.

Classifications MeSH